Investec Bank Plc has filed a Form 8.5 public dealing disclosure under Rule 8.5 of the Takeover Code relating to Advanced Medical Solutions Group Plc (AMS.L).
The disclosure identifies Investec as acting in its capacity as Advisor and Joint Broker to Advanced Medical Solutions Group Plc in connection with the relevant offer.
The dealing was undertaken on 11th September 2026, with the disclosure formally published on 14th September 2026 by Investec Bank Plc.
Under the purchases category, Investec reported acquiring 218,454 ordinary shares at prices ranging between 280.5p and 280.75p per unit during the dealing period.
On the sales side, the bank reported disposing of 1,144,179 ordinary shares, with prices ranging from a low of 280.5p to a high of 281p per unit.
The volume of sales significantly outweighed purchases, with over one million shares sold compared to just over 218,000 shares acquired during the session.
Investec confirmed there were no cash-settled derivative transactions, stock-settled derivative transactions, or other dealings such as subscriptions or conversions to disclose in this filing.
The bank also stated there are no indemnity arrangements, options, or agreements of any kind that could constitute an inducement to deal or refrain from dealing in relevant securities.
Similarly, Investec confirmed no agreements or understandings exist relating to voting rights, future acquisitions, or disposals linked to any derivative referenced in this filing.
The contact named in the disclosure is Priyali Bhattacharjee, and public disclosures of this nature under Rule 8 of the Takeover Code are required to be submitted to a Regulatory Information Service.
The Takeover Panel’s Market Surveillance Unit remains available for consultation regarding dealing disclosure requirements under the Code.
